DOI: 10.12890/2021_002807

Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?

Authors

  • Guillaume Pierman Department of Endocrinology, Centre Hospitalier Universitaire de Mont-Godinne, Yvoir, Belgium
  • Etienne Delgrange Department of Endocrinology, Centre Hospitalier Universitaire de Mont-Godinne, Yvoir, Belgium
  • Corinne Jonas Department of Endocrinology, Centre Hospitalier Universitaire de Mont-Godinne, Yvoir, Belgium

guillaume.pierman@student.uclouvain.be

Keywords

Hyperthyroidism, Graves' disease, vaccine, SARS-CoV-2

Abstract

Graves’ disease is the most frequent cause of hyperthyroidism in young women. This auto-immune disease is due to the production of class 1 IgG stimulating the TSH receptor. These antibodies are produced secondary to a Th1 immune response in which interferon gamma plays a key role. Vaccination is ongoing worldwide against SARS-CoV-2 and some of the vaccines include mRNA which seems to stimulate the Th1 immune response. Here, we report a case of recurrence of hyperthyroidism due to Graves’ disease following mRNA vaccination and discuss the possible implicated mechanism. This observation argues for a systematic study of a population of patients with previous Graves’ disease in order to assess the risk of recurrence following vaccination.

View the entire article

Downloads

References

  1. Vera-Lastra O, Ordinola Navarro A, Pilar Cruz Domiguez M, Medina G, Sanchez Valadez Ti, Jara LJ. Two cases of Grave’s disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid 2021 May 3. doi: 10.1089/thy.2021.0142 (online ahead of print).
  2. Liu EY, Smith LM, Ellis AK, Whitaker H, Law B, Kwong JC, et al. Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario grade 8 HPV vaccine cohort study. CMAJ 2018;190(21):E648–E695. doi: 10.1503/cmaj.170871
  3. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999;354:1691. doi: 10.1016/S0140-6736(99)02429-0
  4. Rapoport B, McLachlan SM. Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab 2014;99:4060. doi: 10.1210/jc.2014-3011
  5. Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. Covid-19 vaccine BNT162b1 elicits human antibody and Th1 T cell responses. Nature 2020;586(7830):594–599. doi: 10.1038/s41586-020-2814-7

Published

2021-10-08

Issue

Vol. 8 No. 9 (2021)

Categories

How to Cite

1.
Pierman G, Delgrange E, Jonas C. Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence? EJCRIM [Internet]. 2021 Oct. 8 [cited 2026 Nov. 3];8(9). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2807

Most read articles by the same author(s)